DocGo Inc.

NASDAQ:DCGO

Medical - Care Facilities

Healthcare
$0.71 -4.29%

-$0.02 today

Market cap
$70.14M
Beta
1.00
P/E (TTM)
-0.3
EPS (TTM)
-$1.90
52W Low $0.49High $1.78

Volume 1.64M

Average 0.87M

DCGO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

DocGo Inc.NASDAQ: DCGO

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares declines year over year

Q1 FY2026 weighted avg shares of 98.75M shares fell 2.8% year over year, in line with the -2.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.8% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.

Context

  • Weighted avg shares increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -2.8% holds above the trailing-twelve-month pace of -2.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
98.75M+0.8% QoQ
Last fiscal yearDec 2025
99.07M-3.2% YoY
LTMMar 2026
98.96M-2.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.8%——
1 year-3.2%——
3-year CAGR-0.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
99.07M USD
Year-over-year change
-3.2%
4-year CAGR
+5.4%

Weighted Avg Shares vs competitors

How DCGO compares with its peers on the latest reported figures

  • DCGO's LTM Mar 2026 weighted avg shares of 98.96M shares is the highest of the 9 companies compared; the peer median is 58.98M shares.
  • Its year-over-year change of -2.8% is the 8th highest of 9, against a peer median of +5.3%.
  • Over three fiscal years its annual growth of -0.7% compares with a peer median of +17.6%.
DCGO Competitors Peer median
Weighted Avg Shares for DCGO and competitors
Company Period LTM YoY 3-year CAGR
DCGODocGo Inc.LTM Mar 202698.96M -2.8%-0.7%
OVIDOvid Therapeutics Inc.LTM Mar 202674.41M +4.8%+1.5%
PRLDPrelude Therapeutics IncorporatedLTM Mar 202674.4M -1.9%+17.6%
VANIVivani Medical, Inc.LTM Mar 202665.65M +15.7%+17.7%
MGNXMacroGenics, Inc.LTM Mar 202663.24M +0.8%+0.9%
MBOTMicrobot Medical Inc.LTM Mar 202654.72M +234.9%+84.8%
IMMXImmix Biopharma, Inc.LTM Mar 202634.62M +19.9%+33.4%
RCELAVITA Medical, Inc.LTM Mar 202621.36M -17.9%+3.7%
COYACoya Therapeutics, Inc.LTM Mar 202616.73M +5.9%+18.9%
Peer median (excluding DCGO) 58.98M+5.3%+17.6%

Competitors are the stored peer set for DCGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue318.72M440.52M624.29M616.56M322.2M
Cost of Revenue208.97M285.79M428.91M402.98M223.44M
Gross Profit109.75M154.72M195.38M213.57M98.76M
Gross Margin34.4%35.1%31.3%34.6%30.7%
Research & Development3.32M5.38M10.86M11.59M13.56M
Selling, General & Admin83.56M116.94M153.04M157.41M158.69M
Operating Expenses94.39M132.89M180.33M184.89M187.91M
Depreciation & Amortization7.51M10.57M16.43M15.88M15.66M
EBITDA28.07M33.35M32.73M45.56M(170.82M)
EBITDA Margin8.8%7.6%5.2%7.4%-53.0%
Operating Income15.36M21.83M15.05M28.69M(89.16M)
Operating Margin4.8%5.0%2.4%4.7%-27.7%
Interest Income0762.69K1.68M236.95K0
Interest Expense763.03K002.17M1.01M
Other Income / Expenses4.44M950.26K1.24M(939.72K)(98.34M)
Income Before Tax19.8M22.78M16.29M27.75M(187.5M)
Pre-Tax Margin6.2%5.2%2.6%4.5%-58.2%
Income Tax Expense615.7K(7.96M)6.24M14.39M8.87M
Net Income23.74M34.58M6.86M19.99M(182.4M)
Net Margin7.4%7.9%1.1%3.2%-56.6%
EPS (Basic)0.300.340.070.20(1.84)
EPS (Diluted)0.250.340.060.18(1.84)
Weighted Avg Shares80.29M101.23M103.51M102.4M99.07M
Weighted Avg Shares (Diluted)94.86M102.98M105.62M109.42M99.07M

DocGo Inc.

NASDAQ:DCGO

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.